Abstract
GEN EdgeVol. 3, No. 1 TopicsThe Upregulation Revolution: CAMP4's Climb to Reach Untouched Diseases by Dialing Up Gene ExpressionBacked by Polaris Partners, co-founders Rick Young PhD and Leonard Zon MD have teamed up to develop tunable gene expression modulators as transformative medicine.Jonathan D. GrinsteinJonathan D. GrinsteinSearch for more papers by this authorPublished Online:27 Jul 2021https://doi.org/10.1089/genedge.3.1.075AboutSectionsView articleView Full TextPDF/EPUB Permissions & CitationsPermissionsDownload CitationsTrack CitationsAdd to favorites Back To Publication ShareShare onFacebookTwitterLinked InRedditEmail View articleFiguresReferencesRelatedDetails Volume 3Issue 1Jan 2021 Information© 2021 by GEN PublishingTo cite this article:Jonathan D. Grinstein.The Upregulation Revolution: CAMP4's Climb to Reach Untouched Diseases by Dialing Up Gene Expression.GEN Edge.Jan 2021.462-467.http://doi.org/10.1089/genedge.3.1.075Published in Volume: 3 Issue 1: July 27, 2021PDF download
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
